Zhubei, Taiwan

Yi-Chun Lin

This inventor holds 1 USPTO granted patent. Top assignee: Gwo Xi Stem Cell Applied Technology Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Chun Lin. Retrieved from https://idiyas.com/inventor/yi-chun-lin-d1utgucd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi-Chun Lin: Innovator in Stem Cell Technology

Introduction

Yi-Chun Lin is a prominent inventor based in Zhubei, Taiwan. He has made significant contributions to the field of stem cell research, particularly in methods aimed at rejuvenating and combating the aging of stem cells. His innovative approach has the potential to impact various medical applications.

Latest Patents

Yi-Chun Lin holds a patent for a method designed for the anti-senescence of and/or rejuvenating stem cells. This method involves treating stem cells with trans-cinnamaldehyde (TC). The patent also includes a kit that comprises a stem cell, TC, and a culture medium, which can be utilized in stem cell therapy. This therapy involves administering an effective amount of treated stem cells to a subject in need.

Career Highlights

Lin is associated with Gwo Xi Stem Cell Applied Technology Co., Ltd., where he continues to advance his research and development in stem cell technology. His work is crucial in exploring new therapeutic avenues for age-related conditions and enhancing the efficacy of stem cell treatments.

Collaborations

Some of his notable coworkers include Tzyy-Wen Chiou and Horng-Jyh Harn, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Yi-Chun Lin's innovative work in stem cell technology exemplifies the potential of scientific research to address aging and rejuvenation. His contributions are paving the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…